跳至主要内容
临床试验/ISRCTN44582462
ISRCTN44582462已完成不适用

An open randomised trial to evaluate different therapeutic strategies of combination therapy for human immunodeficiency virus (HIV-1) Infectio

Medical Research Council (UK)0 个研究点目标入组 1,000 人开始时间: 2005年9月28日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
1,000

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • •The participants in the trial must be HIV-1 infected, over 18 years of age, at any stage of HIV disease, but not acute symptomatic primary infection, where anti-retroviral therapy is indicated. Participants should be likely to take their first regimen for at least 6 months and be expected to adhere to the protocol.

排除标准

  • •1. The participants must not have received prior treatment with antiretroviral drugs or immunotherapy
  • •2. There must be no history of peripheral neuropathy or pancreatitis
  • •3. Individuals must not be receiving combination cytotoxic chemotherapy for cancer or parental therapy for an active opportunistic infection
  • •4. Women should not be pregnant, breastfeeding or unwilling to use adequate contraception
  • •5. Participants will be ineligible if biochemistry and haematology blood results from screening are outside the trial upper safety limits.

研究者

发起方
Medical Research Council (UK)

相似试验

An open randomised trial to evaluate different... | 临床试验